Australia backs tougher regulation for complementary health productsBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7492.619 (Published 17 March 2005) Cite this as: BMJ 2005;330:619
- Bob Burton
The Australian government has backed increased regulation of the complementary health sector after the recommendations of a review, which was initiated after a crisis in the industry. Pan Pharmaceuticals had its licence suspended for six months, and more than 1600 of its products were recalled (BMJ 2003;326:1001).
Parliamentary secretary for health Christopher Pyne said that Australia was “very fortunate to have such a high quality complementary medicines industry” while endorsing stricter regulations outlined in a report by the Expert Committee on Complementary Medicines in the Health System, published last year.
The government …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial